Holding(s) in Company
October 17 2008 - 10:13AM
UK Regulatory
RNS Number : 1435G
Celsis International PLC
17 October 2008
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer CELSIS INTERNATIONAL
of existing shares to which voting rights are PLC
attached:
2. Reason for notification (yes/no)
YES
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) NORTH ATLANTIC VALUE
subject to notification LLP(AS INVESTMENT
obligation: MANAGER/ADVISOR)
1. ORYX
4. Full name of shareholder(s) INTERNATIONAL GROWTH
(if different from 3): FUND LIMITED
2. NORTH ATLANTIC
VALUE LLP (AS
INVESTMENT MANAGER)
10 OCTOBER 2008
5. Date of transaction (and
date on which the threshold is
crossed or reached if
different):
13 OCTOBER 2008
6. Date on which issuer
notified:
TOTAL HOLDING
7. Threshold(s) that is/are INCREASED THROUGH 7%
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction
If possible use ISIN code transaction
Number of shares Number of voting Number of shares Number of voting rights
Percentage of voting
rights rights
Direct Indirect Direct
Indirect
ORDINARY SHARES SEDOL:
B0CD5F6
HOLDER 1
HOLDER 2 1,500,000 1,500,000 1,500,000 1,500,000
6.85%
0 0 50,000 50,000
0.23%
TOTAL
7.07%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting
period/date that may be acquired rights
(if the instrument
exercised/converted)
Total (A+B)
Number of voting rights Percentage of voting rights
1,550,000 7.07%
9. Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable:
NOT APPLICABLE
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: NORTH ATLANTIC VALUE LLP IS THE INVESTMENT
MANAGER/ADVISOR IN RESPECT OF THE FULL 7.07%
HOLDING AS IT IS INVESTMENT MANAGER TO HOLDER
1 AS WELL AS THE OTHER CLIENT INCLUDED IN
HOLDER 2.
14 Contact name: BONITA GUNTRIP
15. Contact telephone number: 020 7747 5681
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBOSRWKRRAAA
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart
From Jul 2023 to Jul 2024